Literature DB >> 21216489

Alveolar space filling ratio as a favorable prognostic factor in small peripheral squamous cell carcinoma of the lung.

Yukihiro Watanabe1, Tomoyuki Yokose, Yuji Sakuma, Chikako Hasegawa, Haruhiro Saito, Kozo Yamada, Hiroyuki Ito, Masahiro Tsuboi, Haruhiko Nakayama, Yoichi Kameda.   

Abstract

INTRODUCTION: Squamous cell carcinomas (SqCCs) of the lung can be divided into two types according to the location of primary site; one is central type and another is peripheral type. Many reports on the central type revealed the clinicopathological characteristics relating carcinogenesis, therapeutics and prognosis. On the other hand, those on the peripheral type are very a few and prognostic indicators of peripheral type have not been enough elucidated. The aim of this study was to clarify clinicopathological prognostic factors of small peripheral SqCCs of the lung 30 mm or less.
MATERIALS AND METHODS: We evaluated various 15 clinicopathological parameters in 81 patients with peripheral type SqCCs, which are defined as tumors located in or more peripheral from the third branching bronchus, measuring 30 mm or less in diameter.
RESULTS: Univariate analyses were performed using the log lank test and multivariate analyses using logistic regression model. As a result, two factors had a statistically significant influence on outcome of the patients in the univariate analysis; no relapse was observed in the patients with the ratio of alveolar space filling (ASF) area to tumor area of 70% or more and the maximum diameter of invasive area measuring 10 mm or less in size (P=0.0214, P=0.0373, respectively). Meanwhile, multivariate analysis showed that the ASF ratio of 70% or more significantly affected the outcome of the patients (P=0.0337), however the maximum diameter of invasive area did not (P=0.2136). We could not show the unfavorable prognostic factor contributory to tumor relapse.
CONCLUSIONS: We have shown that the ASF ratio is a significantly favorable prognostic factor for small peripheral type. Especially the focally invasive tumors with ASF ratio of 70% or more might be classified as "a microinvasive carcinoma" of the peripheral SqCCs of the lung and tumors with ASF ratio 100% as noninvasive carcinoma.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21216489     DOI: 10.1016/j.lungcan.2010.12.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  5 in total

1.  Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.

Authors:  Malik Quasir Mahmood; Chris Ward; Hans Konrad Muller; Sukhwinder Singh Sohal; Eugene Haydn Walters
Journal:  Med Oncol       Date:  2017-02-14       Impact factor: 3.064

2.  Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung.

Authors:  Hibiki Udagawa; Genichiro Ishii; Masahiro Morise; Shigeki Umemura; Shingo Matsumoto; Kiyotaka Yoh; Seiji Niho; Hironobu Ohmatsu; Masahiro Tsuboi; Koichi Goto; Atsushi Ochiai; Yuichiro Ohe
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-09       Impact factor: 4.553

3.  Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer-Specific Death in Squamous Cell Carcinoma.

Authors:  Shaohua Lu; Kay See Tan; Kyuichi Kadota; Takashi Eguchi; Sarina Bains; Natasha Rekhtman; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2016-09-28       Impact factor: 15.609

4.  Interstitial growth as an aggressive growth pattern in primary lung cancer.

Authors:  Shigeki Suzuki; Keiju Aokage; Tomoyuki Hishida; Junji Yoshida; Takeshi Kuwata; Chisako Yamauchi; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-25       Impact factor: 4.553

Review 5.  Prognostic factors in resected lung carcinomas.

Authors:  Keith M Kerr; Marianne C Nicolson
Journal:  EJC Suppl       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.